Skip to content
investormap

Sofinnova Partners

Venture capital

RollingLast verified 9 Nov 2026

European life sciences venture capital firm backing healthcare and biotechnology companies from early creation through later development stages.

9 deals in the last 24 months, latest 6 Nov 2026. From its website and its deals in the news.

Key facts

Stages
Pre-seed, Seed, Series A, Series B, Series C+
Sectors
Biotech & pharma, Medtech, Healthtech
Typical round size
€62.5M (median of its recent deals, not a ticket)
Leads rounds
25% of recent deals with a known role
Eligible countries
Not stated
Provider based in
France
Timing
Rolling applications
Focus
life sciences; therapeutics; digital medicine; industrial biotech; medical devices
How to apply
Application form · Apply on their site

Recent deals

Deals in the last 24 months
CompanyRoundSectorsAmountRoleAnnounced
Alethio Therapeutics · United KingdomSeries ABiotech & pharma€80.5Mlead6 Nov 2026
T-TherapeuticsSeries BBiotech & pharma, Healthtech€118.5Mparticipant5 Nov 2026
Neurent Medical · IrelandSeries C+Medtech€62.5Mparticipant11 Feb 2026
BrightHeartSeries AAI & machine learning, Medtech, Healthtech€11Mparticipant8 Jan 2026
QoriumSeries AMaterials & chemistry, Industrial & manufacturing€22Mparticipant11 Nov 2025
AAVantgarde BioSeries BBiotech & pharma, Healthtech€126.3M–3 Nov 2025
NanoPhoria BioscienceSeries ABiotech & pharma, Healthtech€83.5Mlead6 Oct 2025
SafeHealSeries C+Medtech€10Mparticipant10 Sep 2025
Elicit PlantSeries BAgrifood€45Mparticipant14 Nov 2024

Funds

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

Status history

  • 6 Nov 2026: Rolling (first extraction)

Is something out of date?

Suggest an editTakes 10 seconds
What is wrong?

Please do not include names, email addresses or phone numbers of people.

Something else wrong? Report an error.

Work at Sofinnova Partners? Claim this profile to confirm what you invest in.